0 followers
Olaris aims to fundamentally change how diseases are diagnosed and treated. With their pioneering metabolomics platform and machine learning algorithms, they produce personalized “Biomarkers of Response” (BoR) to readily differentiate drug responders (R) from non-responders (NR).
Elizabeth O'Day
Calico
6 followers
Gameto
4 followers
Qualigen Therapeutics
3 followers
Tango Therapeutics
2 followers
Vera Therapeutics
2 followers
Apogee Therapeutics
1 follower
Cargo
1 follower
Capricor Therapeutics
1 follower
Aura Biosciences
1 follower
Edgewise Therapeutics
1 follower
Cartesian Therapeutics
1 follower
Explore companies